Author:
Nasrallah Henry A.,Fedora Rissa,Morton Robert
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference13 articles.
1. Evaluation of the safety, tolerability, and efficacy of Pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study;Ballard;Lancet Neurol.,2018
2. Tardive dyskinesia risk with first and second generation antipsychotics in comparative randomized controlled trails: a meta-analysis;Carbon;World Psychiatry,2018
3. Guide to the management of clozapine-related tolerability and safety concerns;Citrome;Clin. Schizophr. Relat. Psychoses,2016
4. Pimavanseric for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial;Cummings;Lancet,2014
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献